Page last updated: 2024-08-24

simendan and Coronary Occlusion

simendan has been researched along with Coronary Occlusion in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duvall, E; Haavisto, M; Kentala, R; Knuuti, J; Levijoki, J; Nyman, L; Pietilä, M; Roivainen, A; Saraste, A; Saukko, P; Saunavaara, V; Savunen, T; Stark, C; Strandberg, M; Tarkia, M; Teräs, M; Tolvanen, T; Vähäsilta, T1

Other Studies

1 other study(ies) available for simendan and Coronary Occlusion

ArticleYear
Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Heart (British Cardiac Society), 2016, Volume: 102, Issue:6

    Topics: Acute Disease; Animals; Cardiotonic Agents; Coronary Occlusion; Diastole; Disease Models, Animal; Follow-Up Studies; Hydrazones; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Pyridazines; Simendan; Stroke Volume; Swine; Systole; Ventricular Function, Left; Ventricular Remodeling

2016